Frequency of CD8+ regulatory T cells in the multiple sclerosis patients: a systematic review and meta-analysis
Multiple sclerosis (MS) is a neuro-immunological demyelinating disease. From the immunological aspects, it is well accepted that T cells play a pivotal role in the etiology of the disease. T helper (Th) 1 and Th17 cells are thought to be the main pathogenic T cells in the pathogenesis of MS and are known as effector T cells. As the self-reactive T lymphocytes can escape clonal deletion in the thymus and subsequently are released into the periphery, there is an urgent need for peripheral tolerance, which is executed by the specialized regulatory T (Treg) cells. Interestingly, CD8+ regulatory T (Treg) cells have also been identified among lymphocyte subtypes. The peripheral CD8+ Treg cells frequency in MS subjects in comparison with healthy controls is the objective of the current study using the systematic review and meta-analysis. A systematic literature search was carried out using specialized biomedical databases of Pubmed, Pubmed Central, Medline, Google Scholar, Embase and SCOPUS databases without the beginning date restriction until January 2018 in English language. The results were as follows: OR 15.548 (95% confidence interval 1.954–123.742) using the random-effects model. The P value for test of significance of the total OR was examined by the z test and calculated as 0.010 (clearly considered as statistically significant). Based on our findings, the number of CD8+ Treg cells in the blood of MS subjects is significantly different as compared to healthy controls.
KeywordsCD8+ regulatory T cells Multiple sclerosis Meta-analysis Odds ratio
The authors are grateful for the supports of Ilam University of Medical Sciences.
This study was not funded.
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study, formal consent is not required.
- 5.Piri F, Khosravi A, Moayeri A, Moradipour A, Derakhshan S (2016) The effects of dietary supplements of calcium, vitamin D and estrogen hormone on serum levels of OPG and RANKL cytokines and their relationship with increased bone density in rats. J Clin Diagn Res JCDR 10(9):Af01–Aaf04. https://doi.org/10.7860/jcdr/2016/18648.8433 Google Scholar
- 19.Yang C (2005) Diagnosis of multiple sclerosis. Acta Neurol Taiwan 14(4):213Google Scholar
- 21.Kouchaki E, Salehi M, Sharif MR, Nikoueinejad H, Akbari H (2014) Numerical status of CD4+CD25+FoxP3+ and CD8+ CD28-regulatory T cells in multiple sclerosis. Iran J Basic Med Sci 17(4):250Google Scholar
- 22.Crucian B, Dunne P, Friedman H, Ragsdale R, Pross S, Widen R (1995) Alterations in levels of CD28−/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients. Clin Diagn Lab Immunol 2(2):249–252Google Scholar
- 26.Correale J, Villa A (2010) Role of CD8+CD25+Foxp3+ regulatory T cells in multiple sclerosis. Ann Neurol 67(5):625–638Google Scholar
- 30.Michel L, Berthelot L, Pettré S et al (2008) Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor α-chain are excluded from the analysis. J Clin Investig 118(10):3411–3419Google Scholar